Kaleidoscope Venture Capital, Inc. (fka KLDO)

[Reality2]

This is what was done before


On July 13, 2009, the Commission filed its complaint against the Defendants
alleging that they violated the anti-fraud and registration provisions of the
federal securities laws by, among other things, conducting a “pump-anddump”
scheme in which the defendants used a false and misleading public
relations campaign to tout their client MitoPharm Corporation’s products. In
reality, the products did not exist. Otto sold MitoPharm stock at a profit
before its stock price plunged after the close of the promotional campaign.